Recent Antiphospholipid Syndrome News:
- Helpful enzymes vanish in many patients with antiphospholipid syndrome
- Antiphospholipid Antibodies in SLE-TP Predict Disease Severity and Prognosis
- Immunotherapy During Pregnancy Just as Safe as Other Cancer Drugs – MedPage Today
- What Are Some Healthy Foods To Eat During Chemotherapy?: Get The Answer From Harvard …
- Current status of testing intervals for antiphospholipid syndrome testing: a 13-year …
- Current status of testing intervals for antiphospholipid syndrome testing – Oxford Academic
- Standard-Dose DOAC Equally Efficacious as Low-Dose in AF – The Cardiology Advisor
- National Blood Clot Alliance Stop the Clot Channel – YouTube
- Cryopyrin-associated periodic syndromes (CAPS) – Sobi
- Stroke and Multiorgan Failure as the Initial Manifestations of Lupus | Article – Cureus
- FDA grants anticoagulant its orphan drug designation for treating patients with implanted devices
- Systemic Lupus Erythematosus: A Review | Rheumatology – JAMA Network
- Foundation hosts lupus symposium at Michigan State University – WILX
- Exploring the Impact of Different Definitions of SA-AKI on its Outcomes and Incidence
- Noncriteria antiphospholipid antibodies in antiphospholipid syndrome. – Physician’s Weekly
- Past Sinusitis Linked to Rheumatic Disease Incidence – Rheumatology Advisor
- Nontraditional Risk Factors Key in Young Adult Stroke Risk – Medscape
- People Are Just Realising What Doctors Are Actually Doing When They ‘Google’ Symptoms …
- Rapid Growth Projected For Antiphospholipid Syndrome Treatment Market – GlobeNewswire
- Hearing loss induced by primary antiphospholipid syndrome, and its improvement by …
- Cardiac involvement in the catastrophic antiphospholipid syndrome (CAPS) – ScienceDirect.com
- Vintage Victory: Warfarin Versus Apixaban in the Antiphospholipid Arena | Article – Cureus
- Correction to: Comparison of clinical features between patients with anti-synthetase …
- Patients with prior sinusitis have greater rheumatic disease risk – Healio
- Stroke in a Patient With Antiphospholipid Syndrome | Article – Cureus
- Lectures | University of Michigan Medical School Research
- Rheumatology Forum Summit in Chennai: Focus on SLE & APS – The Hindu
- Antiphospholipid Syndrome drugs in development, 2023 – Pharmaceutical Technology
- Antiphospholipid Syndrome Treatment Market Outlook 2024: – openPR.com
- Belinda Nuske and husband Keiron go through surrogacy to have their baby Emmett
- Discussing platelet disorders with advocate Jeanette Jones – Hemophilia News Today
- Can complement activation be the missing link in antiphospholipid syndrome?
- You are what you eat – Taipei Times
- 23 year old stunned to discover she had a stroke – LMFM
- Educational clinical webinars for your CPD portfolio – SelectScience
- Product News: Werfen receives CE mark for Aptiva Antiphospholipid Syndrome reagents
- Cadrenal Therapeutics Provides Fourth Quarter 2023 Corporate Update | BioSpace
- A Case of Non-cirrhotic Portal Hypertension With Antiphospholipid Syndrome.
- Sinusitis May Predict Rheumatic Disease – MedCentral
- Cadrenal Therapeutics Makes Strides with Tecarfarin Development and Strategic Expansion
- UMich researchers find potential treatment target for APS-related thrombocytopenia
- Cadrenal Therapeutics Provides Fourth Quarter 2023 Corporate Update – Yahoo Finance
- Woman treated for rare bleeding disorder | Pune News – Times of India
- Sinusitis linked to later autoimmune disease – US study – Juta MedicalBrief
- Navigating Pregnancy Risks with Lupus and Antiphospholipid Syndrome: A Closer Look at …
- IMIDs not tied to adverse pregnancy outcomes overall; lupus, APS linked to preterm birth
- Cureus | Ischemic Stroke as an Initial Manifestation of Antiphospholipid Syndrome in an Adolescent
- ‘I Cope With My Lupus And Hashimoto’s Symptoms Through Ultra-Running’ – Women’s Health
- Issues with pregnancy in systemic lupus – ScienceDirect.com
- Clot Control: Antiphospholipid Syndrome Treatment Market – openPR.com
Antiphospholipid Syndrome News:
- Nine research updates in thrombosis treatment, surveillance and risk prediction.
-
Antiphospholipid syndrome. This review summarizes the main knowledge on the clinical and therapeutic aspects of this syndrome.
-
Antiphospholipid syndrome: frequency, main causes and risk factors of mortality. Thrombotic complications are the most common cause of death in APS.
-
Heart attack: New finding may change the face of treatment
-
Hughes syndrome (antiphospholipid syndrome) and the nervous system.
-
When autoimmune diseases exert neuro-ophthalmic effects
-
Catastrophic antiphospholipid syndrome: The current management approach.
- 2016 review on catastrophic antiphospholipid syndrome.
-
Pregnancy and APS: Results Look Encouraging
-
The Role of Viral Infections and Vaccines in the Pathogenesis of Antiphospholipid Syndrome
-
Anticoagulating patients with high-risk acquired thrombophilias.
-
Infectious, Noninfectious Postoperative Complications More Frequent in Patients With SLE
-
Catastrophic antiphospholipid syndrome: The current management approach.
- Rapidly progressive coronary artery disease as the first manifestation of antiphospholipid syndrome. case report
- C-sections raise blood clot risk; protection urged in new recommendation from American College of Obstetricians and Gynecologists. CBS News,
- Myasthenia gravis is sometimes found in conjunction with antiphospholipid syndrome with: A case report
- Primary antiphospholipid syndrome should be considered as a possible cause of repeated stent thrombosis. Journal of Cardiology Cases.
- Good news for prospective mothers with antiphospholipid syndrome? – Journal of Postgraduate Medicine
- New study suggests that long-term anticoagulation with low molecular weight heparin (LMWH) may be a safe and effective alternative for APS patients who had not responded to warfarin (Coumadin) – Annals of Rhematic Diseases
- Rheumatologist Dr. Doruk Erkan talks about Antiphospholipid Syndrome (APS), the disorder that caused my stroke, in this Q&A with the Hospital for Special Surgery. Read it to learn more about APS. – Dr. Doruk Erkan, Rheumatologist
- Preeclampsia: New Research Reveals Why Preeclampsia More Likely For Some Women – Mattason’s Review